Spherical nucleic acids (SNAs) are nanomaterials typically
consisting
of a nanoparticle core and a functional, dense, and highly oriented
oligonucleotide shell with unusual biological properties that make
them appealing for many applications, including sequence-specific
gene silencing, mRNA quantification, and immunostimulation. When placed
in biological fluids, SNAs readily interact with serum proteins, leading
to the formation of ill-defined protein coronae on the surface, which
can influence the targeting capabilities of the conjugate. In this
work, SNAs were designed and synthesized with functional proteins,
such as antibodies and serum albumin, deliberately adsorbed onto their
surfaces. These particles exhibit increased resistance to protease
degradation compared with native SNAs but still remain functional,
as they can engage in hybridization with complementary oligonucleotides.
SNAs with adsorbed targeting antibodies exhibit improved cellular
selectivity within mixed cell populations. Similarly, SNAs coated
with the dysopsonizing protein serum albumin show reduced macrophage
uptake, providing a strategy for tailoring selective SNA delivery.
Importantly, the protein coronae remain stable on the SNAs in human
serum, exhibiting a less than 45% loss of protein through exchange
after 12 h at 37 °C. Taken together, these results show that
protein–SNA complexes and the method used to prepare them provide
a new avenue for enhancing SNA stability, targeting, and biodistribution.